BB Biotech acquires holdings in companies in the biotechnology growth market and is currently one of the world’s largest investors in the sector. BB Biotech is listed in Switzerland, in Germany and in Italy. The focus of the holdings is on quoted companies that are concentrating on the development and marketing of innovative medicines. For the selection of holdings, BB Biotech relies on fundamental analysis by physicians and molecular biologists. The Board of Directors has many years of industrial and scientific experience.